S&P 500
(-0.41%) 5 460.48 points
Dow Jones
(-0.12%) 39 119 points
Nasdaq
(-0.71%) 17 733 points
Oil
(-0.34%) $81.46
Gas
(-3.13%) $2.60
Gold
(0.01%) $2 336.90
Silver
(0.61%) $29.44
Platinum
(0.28%) $1 009.00
USD/EUR
(-0.06%) $0.933
USD/NOK
(0.45%) $10.68
USD/GBP
(-0.05%) $0.791
USD/RUB
(0.86%) $85.73

Realaus laiko atnaujinimai Perspective Therapeutics, [CATX]

Birža: NYSE Sektorius: Healthcare Pramonė: Medical - Devices
Atnaujinta28 birž. 2024 @ 23:00

1.01% $ 9.97

Live Chart Being Loaded With Signals

Commentary (28 birž. 2024 @ 23:00):
Our systems believe the stock currently is overvalued by -1.15% compare to its pairs and should correct downwards.

Perspective Therapeutics, Inc., together with its subsidiaries, develops, manufactures, sells, and markets isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally...

Stats
Šios dienos apimtis 7.95M
Vidutinė apimtis 749 104
Rinkos kapitalizacija 672.28M
EPS $-0.0369 ( Q1 | 2023-09-30 )
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -5.86
(Sector) 49.64
(Industry) 37.79
ATR14 $0.0480 (0.49%)
ABT -0.71%
ALUR -23.26%
AORT 3.22%
AVNS 1.63%
BFLY -3.33%
BFLY-WT 4.91%
BIO 0.41%
BIO-B 0.00%
BSX 0.01%
BSX-PA 2.37%
CATX 1.01%
CNMD 2.70%
CRY 1.42%
EW -1.04%
FNA 2.86%
GKOS 0.83%
GMED -0.52%
INSP -1.11%
ITGR 1.10%
MDT 0.10%
NVRO 0.72%
OWLT 6.46%
PEN 2.90%
PHG -1.87%
RBOT -15.78%
SNN 0.12%
SONX 0.00%
STE 1.43%
SYK 0.15%
VAPO -1.87%
ZBH 0.14%
Insider Trading
Date Person Action Amount type
2024-06-20 Williamson Robert F Iii Buy 23 000 Stock option (right to buy)
2024-06-20 Morich Frank Buy 23 000 Stock option (right to buy)
2024-06-20 Woods Lori A Buy 23 000 Stock option (right to buy)
2024-06-20 Henson Heidi Buy 23 000 Stock option (right to buy)
2024-06-20 Spoor Johan M. Buy 500 000 Stock option (right to buy)
INSIDER POWER
99.90
Last 36 transactions
Buy: 62 148 790 | Sell: 30 000
Koreliacija (AI algo v.1.1b): Overvalued: -1.15% $9.97 paired level. (Algoritmas realiuoju laiku stebi didžiausią koreliaciją turinčių akcijų pokyčius ir suteikia momentinę informaciją)

Tūris Koreliacija

Ilgas: 0.35 (neutral)
Trumpas: 0.02 (neutral)
Signal:(51.197) Neutral

Perspective Therapeutics, Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
KLG0.836
GAQ0.823
ECCC0.819
SBXC0.819
10 Labiausiai neigiamai susiję koreliacijos
AIU-0.865
CCG-0.832
BBAI-WT-0.828
QBTS-0.82
GETR-0.807
RTO-0.806

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Perspective Therapeutics, Koreliacija - Valiuta/Žaliavos

The country flag -0.30
( neutral )
The country flag -0.14
( neutral )
The country flag 0.00
( neutral )
The country flag -0.35
( neutral )
The country flag 0.00
( neutral )
The country flag 0.41
( neutral )

Perspective Therapeutics, Finansinės ataskaitos

Annual 2022
Pajamos: $7.10M
Bruto pelnas: $1.63M (23.00 %)
EPS: $-0.100
FY 2022
Pajamos: $7.10M
Bruto pelnas: $1.63M (23.00 %)
EPS: $-0.100
FY 2022
Pajamos: $10.80M
Bruto pelnas: $4.62M (42.76 %)
EPS: $-0.0504

Financial Reports:

No articles found.

Perspective Therapeutics, Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Perspective Therapeutics,

Perspective Therapeutics, Inc., together with its subsidiaries, develops, manufactures, sells, and markets isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and neck, gynecological, pelvic/abdominal, and colorectal cancers. It sells its products to facilities or physician practices that utilize various surgical facilities. The company was formerly known as Isoray, Inc. and changed its name to Perspective Therapeutics, Inc. in February 2022. Perspective Therapeutics, Inc. was founded in 1998 and is based in Richland, Washington.

Apie Signalai gyvai

Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.

Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.

Total Execution Time: 2.5603790283203 seconds
Number of API calls: 3
Number of DB calls: 9